Department of Pharmacology and Toxicology
Pharmacology and Toxicology was established as a department at Georgia Regents University in 1943. The Department
has a rich history of accomplishments in fundamental research including the discovery
of the adrenergic receptor subtypes-alpha and beta- which has lead to the development
of many drugs used in the treatment of cardiovascular disease. Our research programs
focus on cardiovascular studies and neuroscience studies.
2013 Armand M. Karow Award
Fifth-year graduate student Paramita Pati was named the recipient of the 2013 Armand M. Karow Award. Each year the Department of Pharmacology and Toxicology recognizes a deserving graduate student with this distinction. The $5000 award was established in Professor Karow’s honor through the generosity of the Karow family. Dr. Karow joined the faculty of the Medical College of Georgia in 1968, and was Professor of Pharmacology and Research Associate Professor of Surgery. He was given the title of Professor Emeritus upon his retirement in 1997. Professor Karow was recognized as one of the world’s experts in cryopreservation of transplantable cells and tissues and he published over 100 research articles. Dr. Karow was also the Founder and Chairman Emeritus in Perpetuity of Xytex International, Ltd.
Ms. Pati is investigating the role of the circadian clock in hypertension under the mentorship of Dr. R. Daniel Rudic, Associate Professor of Pharmacology and Toxicology. Ms. Pati has presented her findings at the annual meetings of the Society for Experimental Biology and the Society for Research on Biological Rhythms. She is also the recipient of an American Heart Association Pre-Doctoral Fellowship. Following completion of her dissertation and post-doctoral training, Ms. Pati looks forward to a biological research career in academia.
MCG Alumni Weekend
Dr. Manasses C. Fonteles (left) talks with Dr. Willie Caldwell during his visit to Augusta for the MCG Alumni Weekend on April 26, 2013. He also presented a departmental seminar on “Guanylin Peptides: New Pharmacological Perspectives” before attending the Experimental Biology ’13 meeting in Boston.